Observations placeholder
Zenapax
Identifier
020397
Type of Spiritual Experience
Number of hallucinations: 8
Background
A description of the experience
Daclizumab (trade name Zenapax) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney transplants. The drug is also under investigation for the treatment of multiple sclerosis.
Adverse effects
Common side effects with a frequency of at least 10% include sleeplessness, tremor, headache, arterial hypertension, dyspnoea, gastrointestinal side effects and oedema. In rare cases, the drug can cause severe anaphylaxis.
On Feb, 18, 2016: 1,159 people reported to have side effects when taking Zenapax. Among them, 8 people (0.69%) have Hallucination.
Time on Zenapax when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 18, 2016: 1,159 people reported to have side effects when taking Zenapax. Among them, 4 people (0.35%) have Death.
Time on Zenapax when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 50.00% | 50.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |